Announced together with its joint venture partner and global biotechnology firm, Austrianova— a major ...
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:BIOA),(NYSE:LCTX),(NASDAQ:FATE) EQNX::TICKER_END
Announced that in collaboration with its joint venture partner, Austrianova, a global biotechnology ...
Las Vegas, NV – April 7, 2026 – Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related...
Announced--together with its joint venture partner and global biotechnology firm, Austrianova--the initiation ...
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:NTLA),(NASDAQ:NAGE),(NASDAQ:OCGN) EQNX::TICKER_END
Announced the completion of its corporate name change to Avaí Bio, Inc. The rebranding, effective today, ...
Announced its participation in the 15th European Pancreas and Islet Transplantation Association (EPITA) ...
Highlights the essential importance of cell encapsulation technology in enabling effective, long-term ...
Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that metabolic dysfunction...